Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax. - Wikidata - wikimedia - TriplyDB

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

http://www.wikidata.org/entity/Q37263421

about

Antitoxin Treatment of Inhalation Anthrax: A Systematic Review Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax Efficacy and safety of AVP-21D9, an anthrax monoclonal antibody, in animal models and humans Lessons for control of heroin-associated anthrax in Europe from 2009-2010 outbreak case studies, London, UK Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.Molecular determinants for a cardiovascular collapse in anthrax High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures Effect of anthrax immune globulin on response to BioThrax (anthrax vaccine adsorbed) in New Zealand white rabbits.Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009-2010.Raxibacumab: potential role in the treatment of inhalational anthrax An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule.The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.Anthrax immune globulin improves hemodynamics and survival during B. anthracis toxin-induced shock in canines receiving titrated fluid and vasopressor support.Passive protection against anthrax in mice with plasma derived from horses hyper-immunized against Bacillus anthracis Sterne strain.Disaster Preparedness: Biological Threats and Treatment Options.

P2860

Q28383765-8DC85D6C-EE06-4BF4-BD56-E6C9BCED1975 Q28384806-627B3184-2969-4A62-A8E6-A7EA9649DF03 Q28388590-707A6FB0-D421-4D20-8DEB-023B0FEFB14C Q28388811-AB7AE317-7CC4-48F4-9EBF-25C6A9E0EE81 Q30145641-9D9F43A5-3E43-4A82-8394-77D660A59DE1 Q34960975-581C7992-7D3D-4A90-AD64-74481512B405 Q35205013-EC8EF004-53FB-42D4-B285-96F6C450E50E Q37263339-D4CEF4CB-0812-437E-9682-1EA7FBF68416 Q37524682-5A0A9396-E7CE-4DBB-8521-C39B9D1C235F Q38210540-7CB64586-8B7F-409D-8FEF-218FA9DC854F Q38446682-D555818D-0192-4E34-ADAD-C3E9B13C286C Q38993775-35DF0B55-AE5C-4864-AC4A-604425D4F714 Q40601021-E648E65C-8EB0-48A6-ABE8-16869EFD6E3F Q45894703-6E987CE8-23C9-461E-9593-89007E26A221 Q47135050-F862A253-6B0F-4360-99A8-4C9E64B5A71B Q47558565-119DAAA4-EE41-4629-B0B2-3B7EC05B142D

P2860

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

http://www.wikidata.org/entity/Q37263421

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

@en

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

@nl

type

label

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

@en

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

@nl

prefLabel

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

@en

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

@nl

P1433

Q37263421-90F6DACF-DBAC-4C66-8C70-A8F9A2B8AB60

P1476

Q37263421-DA3AD8CC-DCEC-40D7-8CD5-861A6F58D13D

P2093

Q37263421-1BBD178C-E957-40C5-B3D7-2F0187494BD4

Q37263421-2D12B73D-2028-434F-8EA0-5E14D51BB7DC

Q37263421-3C896613-F368-4E61-A327-841CD68C440C

Q37263421-4460E9A3-284A-401B-90CA-85C7CF4BED50

Q37263421-5F2FECE9-4483-444F-9377-DF6E90A36964

Q37263421-8396DC8A-0D2B-4371-85DE-B56B5D371A23

Q37263421-8DEF86D8-11FE-4B8B-9F0E-AF6199A35858

Q37263421-909C63AB-2034-43C0-AC36-9B31C0E7E5A7

Q37263421-9C7C77A2-E295-4B91-9212-117DBA6AB83E

Q37263421-A4C15CE0-D153-4933-B9D1-7817A7A5E7F6

P2860

Q37263421-0F887E42-1273-4A97-875B-39F52BD3C7A9

Q37263421-12EF0219-12A7-438E-8F4E-68523D828F40

Q37263421-1B409487-11DD-43DE-B124-C1B56570D2E1

Q37263421-23571600-DC6D-443F-B4DE-00FA802280CC

Q37263421-36472007-9475-46DB-AFF6-8DD6401929D8

Q37263421-4322252D-9E9D-417D-8C7E-57C872EDB8DD

Q37263421-462F987C-3E52-4A48-8F94-5F12349B81CC

Q37263421-46937CC4-6C29-4CAA-A05F-FADADB96F7B1

Q37263421-47E14FC2-FA67-40A8-8212-75839FAE36BB

Q37263421-6C6122F0-D267-402C-9817-C6255F2FC399

P304

Q37263421-B978230A-3D18-4603-ABF6-07A87EE4A1E5

P31

Q37263421-B879B705-85BA-4F0B-AB35-466D1A53A86B

P356

Q37263421-3710B22C-720F-4079-B256-EF1BCD12E84B

P407

Q37263421-D1B77D38-76F1-4FE3-A323-1C21D6BB47C6

P433

Q37263421-F2B04A6B-3A92-48F6-B01E-DF77495DD7E1

P478

Q37263421-EEA3C528-A4D0-40C4-9F02-6642D50BCC95

P577

Q37263421-ABC0163A-E0E2-432C-86F5-FDEE6ABD6B94

P5875

Q37263421-94261CC8-5128-459C-AC02-5F386F6D433E

P698

Q37263421-455D29E7-09F6-4ADF-9157-F5F060027011

P932

Q37263421-52A60E4B-B6E2-416D-B6A5-7A800CC76804

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

@en

P2093

Ajoy C Chakrabarti

http://www.w3.org/2001/XMLSchema#string

Boris Ionin

http://www.w3.org/2001/XMLSchema#string

Cris Howard

http://www.w3.org/2001/XMLSchema#string

Daniel C Sanford

http://www.w3.org/2001/XMLSchema#string

Gabriel T Meister

http://www.w3.org/2001/XMLSchema#string

Gary S Nabors

http://www.w3.org/2001/XMLSchema#string

Jason E Comer

http://www.w3.org/2001/XMLSchema#string

Kristopher E Van Zandt

http://www.w3.org/2001/XMLSchema#string

Mario H Skiadopoulos

http://www.w3.org/2001/XMLSchema#string

Mohamed Al-Ibrahim

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene

Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States

Raxibacumab for the treatment of inhalational anthrax

Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen

Anthrax as a biological weapon, 2002: updated recommendations for management

Passive transfer of protection against Bacillus anthracis infection in a murine model.

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.

Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.

Benign ethnic neutropenia: what is a normal absolute neutrophil count?

P304

5684-5692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00458-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256119696

http://www.w3.org/2001/XMLSchema#string

P698

23979731

http://www.w3.org/2001/XMLSchema#string

P932

3811278

http://www.w3.org/2001/XMLSchema#string